Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jutta Piessnegger"'
Introduction and utilisation of high priced HCV medicines across Europe; implications for the future
Autor:
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana Sović Brkičić, Anna Bucsics, Guillame Dedet, Jaran Eriksen, Joseph O Fadare, Jurij Fürst, Gisselle Gallego, Isabella Piassi Godói, Augusto Afonso Guerra Junior, Hakki Gürsöz, Saira Jan, Jan Jones, Saim Kerman, Roberta Joppi, Ott Laius, Newman Madzikwa, Einar Magnusson, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O’Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalene Wladysiuk, Sortiris Vandoros, Elif Hilal Vural, Corinne Zara, Brian Godman
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Background: Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a diagnosed prevalence of 2.0%. Fortunately, it is now curable in most patients. Sales of medicines to treat HCV infection grew 2.7% per year between 20
Externí odkaz:
https://doaj.org/article/442ad35f14564b47bc0809c09511b491
Autor:
Stuart McTaggart, Kristina Garuoliene, Jurij Fürst, Scott M Bryson, Andrew Martin, Winne de Bruyn, Antra Fogele, Agnes Vitry, Hanne Bak Pedersen, Catherine Sermet, Gisbert Selke, Anne Marthe Ringerud, Krijn Schiffers, Eva Andersén Karlsson, Michael Wilcock, Anita Viksna, Irene Langner, Ljiljana Sović-Brkičić, Anna Coma Fusté, Marija Kalaba, Mikael Hoffmann, Peter Skiold, Sisira Jayathissa, Vanda Marković-Peković, Tomasz Bochenek, Einar Magnusson, Ott Laius, Christoph Baumgärtel, Scott Metcalfe, Corinne Zara, Brian Godman, D Tomek, Jutta Piessnegger, Rickard E. Malmström, Juraj Slabý, Harald Herholz, Jessica Fraeyman, Hye-Young Kwon, Marco D’Agata
Publikováno v:
Generics and Biosimilars Initiative Journal. 4:125-135
The manufacturer of pregabalin has a second use patent covering prescribing for neuropathic pain: its principal indication. The manufacturer has threatened legal action in the UK if generic pregabalin rather than Lyrica is prescribed for this indicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19fb38f15e5d3afb567a542ef059014b
https://doi.org/10.5639/gabij.2015.0403.028
https://doi.org/10.5639/gabij.2015.0403.028
Autor:
Kathleen Bennett, Corinne Zara, Steven Simoens, Marie Persson, Brian Godman, Corrado Barbui, Max Petzold, Emanuel Raschi, Andrew Martin, Anna Bucsics, Alexander E. Finlayson, Marion Bennie, Jutta Piessnegger
Publikováno v:
BMC Medicine
Background Generic atypical antipsychotic drugs offer health authorities opportunities for considerable savings. However, schizophrenia and bipolar disorders are complex diseases that require tailored treatments. Consequently, generally there have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9a74aa3be9c833e98a3c33e058c339
http://hdl.handle.net/11585/527040
http://hdl.handle.net/11585/527040
Autor:
Lars L. Gustafsson, Sisira Jayathissa, Roberta Joppi, Anna Brzezinska, Ott Laius, Stephen Campbell, Menno van Woerkom, Kristina Garuoliene, Janet Wale, Vera Vlahović-Palčevski, Marija Kalaba, Krystyna Hviding, Brian Godman, Hanne Bak Pedersen, Samantha Alvarez-Madrazo, Luka Voncina, Anna Bucsics, Corinne Zara, Stuart McTaggart, Iñaki Gutiérrez-Ibarluzea, Eduardo Diogene, Kamila Malinowska, Susan Spillane, Jurij Fürst, Irene Eriksson, Christoph Baumgärtel, Catherine Sermet, Gisbert Selke, D Tomek, Harald Herholz, Magdalena Władysiuk, Jutta Piessnegger, Rickard E. Malmström, Vanda Marković-Peković, Thomas Cars, Alexander E. Finlayson
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Frontiers in Pharmacology
Universitat Autònoma de Barcelona
Frontiers in Pharmacology
Background: There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are effectiveness, safety and/or budget concerns. Dabigatran, a new oral anticoagulant for the prevention of stroke in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7d62ad27b230e7d9b89c69e4251beb7
https://ddd.uab.cat/record/185059
https://ddd.uab.cat/record/185059
Publikováno v:
Southern Med Review
Objective: The objective of this study was to provide an overview about the existence and types of discounts and rebates granted to public payers by the pharmaceutical industry in European countries. Methods: Data were collected via a questionnaire i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26d45be5a7b24e7d28d441a839598b55
https://pubmed.ncbi.nlm.nih.gov/23093898
https://pubmed.ncbi.nlm.nih.gov/23093898
Autor:
Manuela Schmitzer, Marion Bennie, Corrado Barbui, Lars L. Gustafsson, Brian Godman, Thomas Burkhardt, Anna Bucsics, Emanuel Raschi, Jutta Piessnegger
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 3 (2013)
Frontiers in Pharmacology, Vol 3 (2013)
Background: Scrutiny over pharmaceutical expenditure is increasing leading to multiple reforms. This includes Austria with measures to lower generic prices and enhance their utilization. However the situation for newer antidepressants and atypical an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20030892e337a21188fe96b5ad05bd92
https://pubmed.ncbi.nlm.nih.gov/23308071
https://pubmed.ncbi.nlm.nih.gov/23308071